CVS Health Outlines New Revenue Targets, AI Upgrades At Investor Day

CVS Health Inc. (NYSE:CVS) outlined its future growth plans at its investor day on Tuesday.CVS Health stock is charging ahead with explosive momentum. Why is CVS stock surging?Raising Fiscal 2025 OutlookCVS projected 2025 revenue of at least 400billionversustheconsensusof400 billion versus the consensus of 394.59 billion, with operating income of 4.37billionto4.37 billion to 4.54 billion. The drug retailer raised its sales guidance from at least 397.3billion.Thehealthcaregiantraiseditsfiscal2025adjustedearningsguidancefrom397.3 billion.The healthcare giant raised its fiscal 2025 adjusted earnings guidance from 6.55-$6.6 ...